Glomerulonephritis clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)
Sorry, in progress, not accepting new patients
This is a phase 3 study to evaluate effects on proteinuria and glomerular filtration rate of sibeprenlimab 400 mg subcutaneously (s.c.) Q 4 weeks in adults with IgAN who are receiving maximally tolerated standard-of-care therapy.
La Jolla, California and other locations
Last updated: